FR2953725B1 - Procede pour obtenir un extrait standardise de quercetine et de 3-o-methylquercetine a partir d'inflorescences de macela-do-campo, et composition cosmetique, pharmaceutique et veterinaire le contenant - Google Patents

Procede pour obtenir un extrait standardise de quercetine et de 3-o-methylquercetine a partir d'inflorescences de macela-do-campo, et composition cosmetique, pharmaceutique et veterinaire le contenant

Info

Publication number
FR2953725B1
FR2953725B1 FR0959012A FR0959012A FR2953725B1 FR 2953725 B1 FR2953725 B1 FR 2953725B1 FR 0959012 A FR0959012 A FR 0959012A FR 0959012 A FR0959012 A FR 0959012A FR 2953725 B1 FR2953725 B1 FR 2953725B1
Authority
FR
France
Prior art keywords
macela
methylquercetin
campo
inflorescence
quercetin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0959012A
Other languages
English (en)
Other versions
FR2953725A1 (fr
Inventor
Moura Sa Rocha Vanessa De
Junior Sergio Delarcina
Beda Debora Figueiredo
Marcio Lorencini
Beber Tiago Costa
Alan Passero
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Natura Cosmeticos SA
Original Assignee
Natura Cosmeticos SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natura Cosmeticos SA filed Critical Natura Cosmeticos SA
Priority to FR0959012A priority Critical patent/FR2953725B1/fr
Priority to EP11710252.5A priority patent/EP2512495B1/fr
Priority to ES11710252.5T priority patent/ES2553869T3/es
Priority to BR112012014566A priority patent/BR112012014566A2/pt
Priority to PCT/IB2011/000015 priority patent/WO2011073961A1/fr
Priority to US13/515,740 priority patent/US20130012577A1/en
Publication of FR2953725A1 publication Critical patent/FR2953725A1/fr
Application granted granted Critical
Publication of FR2953725B1 publication Critical patent/FR2953725B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
FR0959012A 2009-12-15 2009-12-15 Procede pour obtenir un extrait standardise de quercetine et de 3-o-methylquercetine a partir d'inflorescences de macela-do-campo, et composition cosmetique, pharmaceutique et veterinaire le contenant Expired - Fee Related FR2953725B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR0959012A FR2953725B1 (fr) 2009-12-15 2009-12-15 Procede pour obtenir un extrait standardise de quercetine et de 3-o-methylquercetine a partir d'inflorescences de macela-do-campo, et composition cosmetique, pharmaceutique et veterinaire le contenant
EP11710252.5A EP2512495B1 (fr) 2009-12-15 2011-01-06 Procede pour obtenir un extrait standardise de quercetine et de 3-o-methylquercetine a partir d'inflorescences de macela-do-campo, et composition cosmetique, pharmaceutique et veterinaire le contenant
ES11710252.5T ES2553869T3 (es) 2009-12-15 2011-01-06 Procedimiento para obtener un extracto estandarizado de quercetina y 3-O-metilquercetina a partir de flores de marcela (Achyrocline satureioides), y composiciones cosméticas y farmacéuticas que comprenden dicho extracto
BR112012014566A BR112012014566A2 (pt) 2009-12-15 2011-01-06 Processo para obter um extrato padronizado de quercetina um 3-0-metilquercetina de flores de macela (achyrocline satureioides), e composições cosméticas e farmacêuticas compreendendo o referido extrato
PCT/IB2011/000015 WO2011073961A1 (fr) 2009-12-15 2011-01-06 Procédé d'obtention d'un extrait standardisé de quercétine et de 3-o-méthylquercétine à partir de fleurs de macela, compositions cosmétique, pharmaceutique et vétérinaire contenant ledit l'extrait
US13/515,740 US20130012577A1 (en) 2009-12-15 2011-01-06 Process to obtain a standardized extract of quercetin and 3-o-methylquercetin from inflorescences of macela-do-campo, a cosmetic, pharmaceutical and veterinary composition containing extract of macela-do-campo, the use of this extract and the method of application of the aforesaid extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0959012A FR2953725B1 (fr) 2009-12-15 2009-12-15 Procede pour obtenir un extrait standardise de quercetine et de 3-o-methylquercetine a partir d'inflorescences de macela-do-campo, et composition cosmetique, pharmaceutique et veterinaire le contenant

Publications (2)

Publication Number Publication Date
FR2953725A1 FR2953725A1 (fr) 2011-06-17
FR2953725B1 true FR2953725B1 (fr) 2015-10-23

Family

ID=42242629

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0959012A Expired - Fee Related FR2953725B1 (fr) 2009-12-15 2009-12-15 Procede pour obtenir un extrait standardise de quercetine et de 3-o-methylquercetine a partir d'inflorescences de macela-do-campo, et composition cosmetique, pharmaceutique et veterinaire le contenant

Country Status (6)

Country Link
US (1) US20130012577A1 (fr)
EP (1) EP2512495B1 (fr)
BR (1) BR112012014566A2 (fr)
ES (1) ES2553869T3 (fr)
FR (1) FR2953725B1 (fr)
WO (1) WO2011073961A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022027122A1 (fr) * 2020-08-06 2022-02-10 Ramade & Cia Holding Corp. Compositions contenant des cannabinoïdes de cannabis sativa pour le traitement du dysfonctionnement érectile et sexuel

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5944313B2 (ja) 1974-11-26 1984-10-29 中外製薬株式会社 インダゾ−ル誘導体の製法
JPS5944313A (ja) * 1982-09-07 1984-03-12 Yakult Honsha Co Ltd 抗菌性組成物
US5679806A (en) * 1995-02-24 1997-10-21 Hauser, Inc. Process for the isolation and purification of isoflavones
JPH10226619A (ja) 1997-02-17 1998-08-25 Shiseido Co Ltd 皮膚外用剤
EP1260212A1 (fr) 2001-05-21 2002-11-27 Cognis France S.A. Composition cosmetique
BR0103468A (pt) * 2001-07-12 2003-07-29 Univ Fed Do Rio Grande Do Sul Processo para obtenção de extratos de achyrocline satureioides e produto obtido
US20030165588A1 (en) 2002-03-01 2003-09-04 Unigen Pharmaceuticals, Inc. Identification of free-B-ring flavonoids as potent COX-2 inhibitors
BRPI0409179A (pt) 2003-04-04 2006-05-02 Unigen Pharmaceuticals Inc formulação de inibidores duplos de ciclooxigenase (cox) e lipoxigenase (lox) para cuidados com a pele de mamìferos
EP1475097A3 (fr) * 2003-05-08 2004-12-01 Dajas Mendez, José Federico compositions cosmétiques comprenant un extrait d'achyrocline sp (marcela), utilisation et procédé de préparation
US20080070875A1 (en) * 2006-09-11 2008-03-20 Majewski George P Acne treatment compositions and methods of use

Also Published As

Publication number Publication date
FR2953725A1 (fr) 2011-06-17
US20130012577A1 (en) 2013-01-10
ES2553869T3 (es) 2015-12-14
BR112012014566A2 (pt) 2017-09-05
WO2011073961A1 (fr) 2011-06-23
EP2512495B1 (fr) 2015-09-09
EP2512495A1 (fr) 2012-10-24

Similar Documents

Publication Publication Date Title
EP2508523A3 (fr) Polymorphes de dasatinib et leur procédé de préparation
PL2192911T3 (pl) Roślinny ekstrakt z konopi ubogich w THC do leczenia chorób
AP2012006135A0 (en) Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof.
FR2948565B1 (fr) Composition cosmetique pour le traitement de l'acne comprenant un extrait petidique de schizandra
IL190646A0 (en) Multi-functional ionic liquid compositions for overcoming polymorphism and imparting improved properties for active pharmaceutical, biological, nutritional, and energetic ingredients
IL208203A (en) Annotations of 3,2-Dihydro-Pyrido-4,1-Exazine and 3,2-Dihydro-4-Oxa-9,1-Diazapananthrene, Preparation Processes and Pharmaceutical Preparations
EP1895966A4 (fr) Procede d'extraction de ginsenoside rg2, composition pharmaceutique comprenant du ginsenoside rg2, et utilisations associees
FR2934596B1 (fr) Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation
SI2036892T1 (sl) Derivati tetrahidro h benzazepinov postopek za njihovo pripravo in farmacevtski sestavkiki jih vsebujejo
FR2943342B1 (fr) Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2010127205A3 (fr) Formulations de combinaison de médicament à dose fixe
FR2904557B1 (fr) Nouvel extrait d'eucalyptus, son procede de preparation et ses utilisations therapeutiques
HK1116426A1 (en) Chinese medicinal compositions for treating headache, formulations and processes for preparation thereof
FR2929852B1 (fr) Procede de preparation d'extrait vegetal riche en polyphenols, extrait obtenu a partir du procede, compositions renfermant ledit extrait et installation pour la mise en oeuvre du procede
FR2934160B1 (fr) Procede de preparation d'un extrait lipophile de vigne.
FR2957923B1 (fr) Nouvel extrait d'halymenia durvillei, procede pour preparer un tel extrait et son utilisation cosmetique
FR2945448B1 (fr) Procede de preparation d'une formulation pharmaceutique de chelate de lanthanide sous forme de poudre.
FR2953725B1 (fr) Procede pour obtenir un extrait standardise de quercetine et de 3-o-methylquercetine a partir d'inflorescences de macela-do-campo, et composition cosmetique, pharmaceutique et veterinaire le contenant
FR2896686B1 (fr) Procede de preparation d'une composition cosmetique, appareil et recharge pour la preparation d'une telle composition
HK1126190A1 (en) Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
EP2276729A4 (fr) Nouveaux composés dérivés de taurine, processus de préparation de ces composés et composition pharmaceutique les contenant
IL213792A0 (en) Novel oxime derivatives of 3, 5-seco-4-nor-cholestane, pharmaceutical compositions containing the same and method for preparing the same
FR2874502B1 (fr) Nouvel extrait vegetal, son procede d'obtention et ses applications pharmaceutiques, nutraceutiques ou cosmetiques
FR2950532B1 (fr) Procede pour la preparation d'un extrait de plantes du genre sclerolobium, composition cosmetique et pharmaceutique comprenant cet extrait et utilisation dudit extrait
EP2586432A3 (fr) Co-cristaux de Tramadol et NSAID tels que des Coxibs

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

ST Notification of lapse

Effective date: 20190905